Related Experiment Video
Updated: Oct 2, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Prescribers' beliefs and values as predictors of drug choices
Abstract:
A cognitive model of the drug-prescribing process, which incorporates prescribers' attitudes (valences) about treatment outcomes and beliefs (instrumentalities) about drug effects, was tested. Twelve physicians were interviewed to identify common outcomes associated with drug therapy; six distinct outcomes were identified. Then 50 family practice residents were given a hypothetical description of a mildly hypertensive patient and three treatment choices. The physicians completed a questionnaire that identified (1) the instrumentalities of each of the alternative treatments for each of the six outcomes and (2) the valences for each outcome. The physicians were also asked to respond to an open-ended question on how they would treat the patient described in the case. Forty-six physicians proposed 39 treatments that corresponded to the three treatments for which instrumentalities and valences were available. The drug-choice model correctly predicted 28 of 39 (72%) therapeutic decisions, which was significantly more than would be expected by chance (p less than 0.01). Both valences and instrumentalities appear important for predicting prescribing intention. Pharmacists can use this model in their attempts to influence prescribing.
Related Concept Videos
Factors Affecting Drug Response: Overview
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Abuse and Addiction: Pharmacological Phenomena
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Drug Dosing: Geriatric Patients
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu